These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 205451)
1. Enzyme therapy--IX. Stabilization of human splenic alpha-galactosidase a by zinc ion. Thorpe SR; Desnick RJ Int J Biochem; 1978; 9(2):103-5. PubMed ID: 205451 [No Abstract] [Full Text] [Related]
2. Plasma alpha-galactosidase A:properties and comparisons with tissue alpha-galactosidases. Bishop DF; Sweeley CC Biochim Biophys Acta; 1978 Aug; 525(2):399-409. PubMed ID: 210818 [TBL] [Abstract][Full Text] [Related]
3. Effect of detergents on ceramide-3 hydrolysis by alpha-galactosidase A. Schram AW; Ho MW; Cordus S; Samson M; Hamers MN; Brown J; Robinson D; Tager JM Adv Exp Med Biol; 1978; 101():531-5. PubMed ID: 208366 [No Abstract] [Full Text] [Related]
4. Activator protein for the degradation of globotriaosylceramide by human alpha-galactosidase. Gärtner S; Conzelmann E; Sandhoff K J Biol Chem; 1983 Oct; 258(20):12378-85. PubMed ID: 6313655 [TBL] [Abstract][Full Text] [Related]
5. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease. Mayes JS; Scheerer JB; Sifers RN; Donaldson ML Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521 [TBL] [Abstract][Full Text] [Related]
6. Lysosomal enzyme activities of human fetal organs during development. Shin-Buehring YS; Dallinger M; Osang M; Rahm P; Schaub J Biol Neonate; 1980; 38(5-6):300-8. PubMed ID: 6251927 [TBL] [Abstract][Full Text] [Related]
7. Isoenzyme profiles of lysosomal hydrolases in leukaemic cells. Dewji N; Rapson N; Greaves M; Ellis R Leuk Res; 1981; 5(1):19-27. PubMed ID: 6262581 [No Abstract] [Full Text] [Related]
8. [2 different beta-galactosidases in the colonic mucosal cells of the rat. I. Latency of lysosomal beta-galactosidase and partial solubilization of a "neutral" one, bound to a membrane]. Storelli C; De Michele L; Storelli-Joss C Boll Soc Ital Biol Sper; 1977 Aug; 53(15):1284-8. PubMed ID: 23807 [No Abstract] [Full Text] [Related]
9. Studies on human liver alpha-galactosidases. I. Purification of alpha-galactosidase A and its enzymatic properties with glycolipid and oligosaccharide substrates. Dean KJ; Sweeley CC J Biol Chem; 1979 Oct; 254(20):9994-10000. PubMed ID: 39940 [No Abstract] [Full Text] [Related]
10. Genetic determination of the alpha-galactosidase developmental program in mice. Lusis AJ; Paigen K Cell; 1975 Nov; 6(3):371-8. PubMed ID: 212204 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of alpha-galactosidase. Mathew CD; Balasubramaniam K Indian J Biochem Biophys; 1987 Oct; 24(5):suppl 29-32. PubMed ID: 2835309 [No Abstract] [Full Text] [Related]
12. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells. Johnson DL; Desnick RJ Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178 [No Abstract] [Full Text] [Related]
13. Factors that influence the uptake and turnover of glucocerebrosidase and alpha-galactosidase in mammalian liver. Pentchev PG; Kusiak JW; Barranger JA; Furbish FS; Rapoport SI; Massey JM; Brady RO Adv Exp Med Biol; 1978; 101():745-52. PubMed ID: 208371 [No Abstract] [Full Text] [Related]
14. Purification and partial characterization of human liver alpha-galactosidase: is alpha-galactosidase B an alpha-N-acetylgalactosaminidase? Dean KJ; Sung SS; Sweeley CC Adv Exp Med Biol; 1978; 101():515-23. PubMed ID: 208364 [No Abstract] [Full Text] [Related]
15. Studies on human liver alpha-galactosidases. II. Purification and enzymatic properties of alpha-galactosidase B (alpha-N-acetylgalactosaminidase). Dean KJ; Sweeley CC J Biol Chem; 1979 Oct; 254(20):10001-5. PubMed ID: 226532 [No Abstract] [Full Text] [Related]
16. Enzyme therapy XVII: metabolic and immunologic evaluation of alpha- galactosidase A replacement in Fabry disease. Desnick RJ; Dean KJ; Grabowski GA; Bishop DF; Sweeley CC Birth Defects Orig Artic Ser; 1980; 16(1):393-413. PubMed ID: 6256019 [TBL] [Abstract][Full Text] [Related]
17. Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes. Desnick RJ; Dean KJ; Grabowski G; Bishop DF; Sweeley CC Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5326-30. PubMed ID: 228284 [TBL] [Abstract][Full Text] [Related]
18. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase]. Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612 [TBL] [Abstract][Full Text] [Related]
19. Affinity purification of alpha-galactosidase A from human spleen, placenta, and plasma with elimination of pyrogen contamination. Properties of the purified splenic enzyme compared to other forms. Bishop DF; Desnick RJ J Biol Chem; 1981 Feb; 256(3):1307-16. PubMed ID: 6256390 [TBL] [Abstract][Full Text] [Related]
20. Isozymes of alpha-galactosidase from Bacillus stearothermophilus. Pederson DM; Goodman RE Can J Microbiol; 1980 Aug; 26(8):978-84. PubMed ID: 6257360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]